Arcadia Biosciences, Inc.
RKDA Consumer Defensive Packaged Foods
Arcadia Biosciences, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $4.9 million, down 3.71% from fiscal 2024. In the quarter to June 2026, revenue was flat, EPS grew 35.9% and free cash flow grew 82.1%, each against the same quarter a year earlier.
Follow RKDA
Arcadia Biosciences, Inc. (RKDA) EV/Sales
As of 16 October 2026, Arcadia Biosciences, Inc. (RKDA) trades at a EV/Sales of −0.8×. Over the past ten years it has ranged from −8.7× (March 2020) to 27.7× (March 2018); the current reading is higher than 23% of that period. That is below the Packaged Foods industry median of 0.9× and below the Consumer Defensive sector median of 1.0×.
EV/Sales, daily
Embed this chart
Annual newest first
| Period | EV/Sales | Change |
|---|---|---|
| FY2025 | −0.4× | — |
| FY2024 | 0.8× | — |
| FY2023 | −1.8× | — |
| FY2022 | −1.9× | — |
| FY2021 | −0.9× | — |
| FY2020 | 0.3× | (95.82%) |
| FY2019 | 8.3× | 8.37% |
| FY2018 | 7.6× | 56.24% |
| FY2017 | 4.9× | 7.26% |
| FY2016 | 4.6× | (59.89%) |
Quarterly newest first
| Period | EV/Sales | Change |
|---|---|---|
| Jun 2026 | −0.4× | — |
| Mar 2026 | −0.2× | — |
| Dec 2025 | −0.4× | — |
| Sep 2025 | −0.2× | — |
| 42 more quarters | Free account |
Against its own ten years
EV/Sales against peers
| Company | EV/Sales |
|---|---|
| RKDA Arcadia Biosciences, Inc. | −0.8× |
| PAVS Paranovus Entertainment Technology Ltd. compare | −0.1× |
| ORISF Oriental Rise Holdings Limited compare | n/m |
| STKH Steakholder Foods Ltd. Sponsored ADR compare | n/m |
| MEHA Functional Brands Inc. compare | 0.2× |
| CYAN Cyanotech Corporation compare | 0.4× |
| RGFC Real Good Food Company, Inc. compare | 0.8× |
| ATPC Agape ATP Corporation compare | 1.2× |
| BSFCD Blue Star Foods Corp. compare | 23.8× |
| Packaged Foods industry median | 0.9× |
| Consumer Defensive sector median | 1.0× |
| Market median | 2.1× |
What EV/Sales is
EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)